Literature DB >> 16424178

CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.

Jennifer D Stone1, Lawrence J Stern.   

Abstract

T cell activation is initiated by recognition of antigenic peptide presented in complex with MHC molecules on the surface of APCs. The mechanism by which this recognition occurs is still unclear, and many models exist in the literature. CD4 T cells have been shown to respond to soluble oligomers of activating class II MHC-peptide complexes, but not to soluble monomers. In determining the reactivity of CD8 T cells to soluble activating class I MHC-peptide complexes, a complicating phenomenon had been observed whereby peptide from soluble complexes was loaded onto cell surface MHCs on the T cells and re-presented to other T cells, clouding the true valency requirement for activation. This study uses soluble allogeneic class I MHC-peptide monomers and oligomers to stimulate murine CD8 T cells without the possible complication of peptide re-presentation. The results show that MHC class I monomers bind to, but do not activate, CD8 T cells whether the cells are in solution or adhered to a surface. Monomeric MHC class I binding can antagonize the stimulation triggered by soluble oligomers, a phenomenon also observed for CD4 T cells. Dimeric engagement is necessary and sufficient to stimulate downstream activation processes including TCR down-regulation, Zap70 phosphorylation, and CD25 and CD69 up-regulation, even in T cells that do not express the MHC coreceptor CD8. Thus, the valency dependence of the response of CD8 T cells to soluble MHC-peptide reagents is the same as previously observed for CD4 T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424178     DOI: 10.4049/jimmunol.176.3.1498

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Quantum dot fluorescence characterizes the nanoscale organization of T cell receptors for antigen.

Authors:  Sarah Boyle; David L Kolin; Joan Glick Bieler; Jonathan P Schneck; Paul W Wiseman; Michael Edidin
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

2.  Bi-specific MHC heterodimers for characterization of cross-reactive T cells.

Authors:  Zu T Shen; Michael A Brehm; Keith A Daniels; Alexander B Sigalov; Liisa K Selin; Raymond M Welsh; Lawrence J Stern
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

3.  The receptor deformation model of TCR triggering.

Authors:  Zhengyu Ma; Paul A Janmey; Terri H Finkel
Journal:  FASEB J       Date:  2007-11-05       Impact factor: 5.191

4.  Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.

Authors:  Arnold H Bakker; Rieuwert Hoppes; Carsten Linnemann; Mireille Toebes; Boris Rodenko; Celia R Berkers; Sine Reker Hadrup; Wim J E van Esch; Mirjam H M Heemskerk; Huib Ovaa; Ton N M Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

Review 5.  T cell antigen recognition at the cell membrane.

Authors:  Jun Huang; Christina Meyer; Cheng Zhu
Journal:  Mol Immunol       Date:  2012-06-07       Impact factor: 4.407

6.  Functional development of the T cell receptor for antigen.

Authors:  Peter J R Ebert; Qi-Jing Li; Johannes B Huppa; Mark M Davis
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

7.  Peptide-MHC heterodimers show that thymic positive selection requires a more restricted set of self-peptides than negative selection.

Authors:  Jeremy Juang; Peter J R Ebert; Dan Feng; K Christopher Garcia; Michelle Krogsgaard; Mark M Davis
Journal:  J Exp Med       Date:  2010-05-10       Impact factor: 14.307

8.  Strategy escalation: an emerging paradigm for safe clinical development of T cell gene therapies.

Authors:  Richard Paul Junghans
Journal:  J Transl Med       Date:  2010-06-10       Impact factor: 5.531

Review 9.  T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.

Authors:  Jennifer D Stone; Adam S Chervin; David M Kranz
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

10.  The impact of TCR-binding properties and antigen presentation format on T cell responsiveness.

Authors:  Adam S Chervin; Jennifer D Stone; Phillip D Holler; Ailin Bai; Jianzhu Chen; Herman N Eisen; David M Kranz
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.